Organization | Ben Gurion University

Ben Gurion University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Beersheba Israel (1959)

Organization Overview

First Clinical Trial

2003

NCT00128791

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Assuta Medical Center | Beersheva Mental Health Center | Be'er Sheva Mental Health Center | Be'er Sheva Mental Health Center Ben Gurion University of the Negev | Beer Sheva Mental Health Center Israel. | Ben-Gurion University of the Negev | Ben-gurion University of the Negev, Beer-Sheva, Israel | Ben Gurion University of the Negev + Beersheva Mental Health Center | Ben-Gurion University of the Negev, Sial Research Center for Family Medicine and Primary Care | Ben-Gurion University of the Negev/Soroka Medical Center | BGU Soroka medical center | Department of Psychology, Ben-Gurion University of the Negev, Israel | Hypertension Clinic of Soroka University Medical Center | Hypertension clinic of the Soroka University Hospital | Internal Medicine Division, Soroka University Medical Center | Prof. RH Belmaker | Roee Landsberg | Soroka Hospital,Beer Sheva,Israel | Soroka Univeersity Medical Center | Soroka University | Soroka University Medical Centar | Soroka University Medical Center | Soroka University Medical Center & Ben Gurion University | Soroka University Medical Center-Department of Anesthesiology | Soroka University Miedical Center | Vladimir Lerner

Active Ingredients

Drugs in Phase 4 Trials (26)

alfuzosin (uroxatral) (1 trial)

budesonide (rhinocort) (1 trial)

cefadroxil (duricef) (1 trial)

choline c11 (choline c-11) (1 trial)

clozapine (clozaril) (2 trials)

creatine (2 trials)

curcumin (2 trials)

deferasirox (exjade) (1 trial)

donepezil (aricept) (2 trials)

fentanyl (Innovar) (2 trials)

ibuprofen (motrin) (1 trial)

inactivated influenza vaccine (1 trial)

iron hydroxide adipate (1 trial)

iron polysaccharide (1 trial)

isosorbide (isordil) (1 trial)

ketamine (ketalar) (1 trial)

midazolam (versed) (1 trial)

montelukast (singulair) (1 trial)

nicotinamide (1 trial)

nitroprusside (nipride) (1 trial)

omeprazole (prilosec) (1 trial)

phenytoin (mesantoin) (1 trial)

pyridoxine (2 trials)

sodium ferric gluconate complex (1 trial)

tamsulosin (flomax) (1 trial)

vitamin c (2 trials)

Drugs in Phase 3 Trials (39)

acetylcysteine (mucomyst) (2 trials)

amisulpride (BARHEMSYS) (1 trial)

bexarotene (targretin) (3 trials)

bismuth (1 trial)

clarithromycin (biaxin) (1 trial)

cyanocobalamin (berocca) (3 trials)

enoxaparin (lovenox) (2 trials)

ethanol (2 trials)

ferritin (1 trial)

folic acid (1 trial)

fructo-oligosaccharide (1 trial)

haloperidol (haldol) (1 trial)

ibritumomab tiuxetan (Zevalin) (1 trial)

icosapent ethyl (vascepa) (1 trial)

indomethacin (indocin) (1 trial)

inulin (1 trial)

iron (2 trials)

lansoprazole (prevacid) (1 trial)

lonafarnib (Zokinvy) (1 trial)

metoclopramide (reglan) (1 trial)

metronidazole (flagyl) (1 trial)

moclobemide (Amira) (1 trial)

n-(4-hydroxyphenyl)all-trans retinamide (1 trial)

nifedipine (procardia) (1 trial)

oxygen (1 trial)

piracetam (1 trial)

prednisone (meticorten) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

progesterone (progestasert) (2 trials)

ritonavir (Norvir) (1 trial)

sitagliptin (januvia) (1 trial)

testosterone (delatestryl) (1 trial)

tetracycline (tetrex) (1 trial)

theanine (1 trial)

tinidazole (tindamax) (1 trial)

valnoctamide (1 trial)

vitamin a (1 trial)

vitamin d3 (5 trials)

zoledronic acid (zometa) (1 trial)

Drugs in Phase 2 Trials (27)

alpha-1 antitrypsin (Prolastin) (1 trial)

amphotericin b (fungizone) (1 trial)

aramchol (2 trials)

attenuated measles vaccine - Edmonston strain (rubeovax) (1 trial)

deoxycholic acid (kybella) (1 trial)

dexamethasone (1 trial)

hydrocortisone (solu-cortef) (1 trial)

ixazomib (ninlaro) (1 trial)

leptospermum honey (1 trial)

levobupivacaine (chirocaine) (1 trial)

maraviroc (selzentry) (1 trial)

morphine (2 trials)

navitoclax (1 trial)

nitric oxide (inomax) (2 trials)

oxycodone (oxycontin) (1 trial)

peginterferon lambda-1a (1 trial)

pentoxifylline (trental) (1 trial)

pomalidomide (pomalyst) (1 trial)

psilocybin (1 trial)

rosuvastatin (crestor) (1 trial)

sodium chloride (3 trials)

temozolomide (temodar) (1 trial)

tosedostat (1 trial)

vaccine against cd4 reactive t cells (1 trial)

valproic acid (depakene) (2 trials)

venetoclax (venclexta) (1 trial)

Drugs in Phase 1 Trials (5)

acetaminophen (tylenol) (2 trials)

oxytocin (syntocinon) (1 trial)

palladium (1 trial)

pregnenolone (1 trial)

promitil (1 trial)

Drugs in Other Trials (23)

aprotinin (trasylol) (1 trial)

atropine (1 trial)

autologous microbiome (1 trial)

colistin (1 trial)

gentamicin (garamycin) (1 trial)

hepatitis b vaccine (recombinant) (Recombivax) (1 trial)

hydrolysed whey protein (1 trial)

hydroxyprogesterone (Delalutin) (1 trial)

insulin human (humulin) (1 trial)

lavender (1 trial)

lidocaine (xylocaine) (1 trial)

mankai (1 trial)

methylphenidate (ritalin) (2 trials)

nicotine (nicorette) (1 trial)

pirfenidone (esbriet) (1 trial)

prolycopene (1 trial)

propofol (diprivan) (1 trial)

sucroferric oxyhydroxide (Venofer) (1 trial)

sunflower oil (1 trial)

tzabar fruit (1 trial)

warfarin (coumadin) (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Abortion, Habitual (Phase 3)

Abortion, Spontaneous (Phase 3)

Acquired Immunodeficiency Syndrome (Phase 2)

Acute Coronary Syndrome (Phase 4)

Aggression (Phase 3)

Alzheimer Disease (Phase 3)

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Angina, Unstable (Phase 4)

Asthma (Phase 4)

Astrocytoma (Phase 1)

Autistic Disorder (Phase 4)

Bacterial Infections (Phase 4)

Bipolar Disorder (Phase 3)

Breast Neoplasms (Phase 3)

Bronchiolitis (Phase 2)

Burns (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Cholecystolithiasis (Phase 2)

Cholelithiasis (Phase 2)

Communicable Diseases (Phase 3)

Cystic Fibrosis (Phase 2)

Dementia (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Diabetes, Gestational (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Diarrhea (Phase 3)

Dyskinesias (Phase 3)

Eclampsia (Phase 2)

Eye Burns (Phase 1)

Fatty Liver (Phase 2)

Fetal Death (Phase 3)

Fever (Phase 4)

Fibrosis (Phase 2)

Gallstones (Phase 2)

Glioblastoma (Phase 2)

HIV Infections (Phase 2)

Hypokinesia (Phase 3)

Infarction (Phase 4)

Infections (Phase 3)

Influenza, Human (Phase 4)

Iron Overload (Phase 4)

Leishmaniasis (Phase 2)

Leishmaniasis, Cutaneous (Phase 2)

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Liver Diseases (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Malnutrition (Phase 3)

Measles (Phase 2)

Metabolic Syndrome (Phase 2)

Myelodysplastic Syndromes (Phase 4)

Myocardial Infarction (Phase 4)

Neoplasm Metastasis (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 2)

Obesity, Morbid (Phase 1)

Obstetric Labor, Premature (Phase 3)

Osteoporosis (Phase 3)

Pancreatic Neoplasms (Phase 2)

Prediabetic State (Phase 3)

Pre-Eclampsia (Phase 3)

Pregnancy in Diabetics (Phase 3)

Preleukemia (Phase 4)

Prosopagnosia (Phase 1)

Psychotic Disorders (Phase 3)

Renal Colic (Phase 4)

Respiratory Aspiration (Phase 4)

Schizophrenia (Phase 4)

Sexual Dysfunctions, Psychological (Phase 3)

Sialorrhea (Phase 3)

Sleep Apnea Syndromes (Phase 4)

Syndrome (Phase 4)

Tardive Dyskinesia (Phase 3)

Thoracic Injuries (Phase 2)

Whiplash Injuries (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 103
# of Trial APIs: 120